Sort
39,280 grants matching “leukemia”
Control of GVHD by Probiotics with individual Commensal Bacteria
$623,934Xue-Zhong Yu · Medical College Of Wisconsin · R01 · FY2022 · HL
A Targeted Nanomedicine Prototype Against Enzalutamide-resistant Prostate Cancer
$623,916Renata Pasqualini · Rbhs -Cancer Institute Of New Jersey · R01 · FY2019 · CA
Tumor Heterogeneity and Acquired Resistance to EGFR Inhibition
$623,897Scott Kopetz · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA
Studies in the Pathogenesis of Systemic Capillary Leak Syndrome
$623,882Kirk Druey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Mutation Mechanisms Leading to Malignant Transformation, Including Chromosomal Translocation and Point Mutations
$623,811Peter Aplan · Division Of Clinical Sciences - Nci · ZIA · FY2024 · CA
Collaborative Pathways that Lead to Leukemia
$623,811Peter Aplan · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Using Mass Spectroscopy to Characterize Transcription Proteins and F2-Isoprostane
$623,770Bettye Henninton · Tougaloo College · P20 · FY2011 · MD
Botswana Birth Outcomes Surveillance Extension
$623,767Roger L Shapiro · Harvard School Of Public Health · R01 · FY2019 · HD
Who Cares For Older Breast Cancer Surivors And How Does It Affect Quality?
$623,747Jeanne Mandelblatt · Georgetown University · R01 · FY2011 · CA
Transition State Analysis of Enzymatic Reactions
$623,731Vern L. Schramm · Albert Einstein College Of Medicine · R01 · FY2008 · GM
Development of A HTLV-1 Vaccine
$623,689Glen N. Barber · University Of Miami School Of Medicine · R01 · FY2021 · CA
A Next-Generation Nucleoside Prodrug for Diffuse Large B-Cell Lymphoma
$623,596Richard T Pomerantz · Thomas Jefferson University · R01 · FY2025 · CA
A Next-Generation Nucleoside Prodrug for Diffuse Large B-Cell Lymphoma
$623,596Richard T Pomerantz · Thomas Jefferson University · R01 · FY2024 · CA
Novel Approaches to CD33-Directed Radioimmunotherapy
$623,487Roland Bruno Walter · Fred Hutchinson Cancer Center · R37 · FY2023 · CA
Neurostimulation in Adult Survivors of Childhood Leukemia
$623,459Tara M Brinkman · St. Jude Children'S Research Hospital · R01 · FY2021 · CA
Mechanisms of epitranscriptomic regulation in cancer
$623,304Samie R Jaffrey · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
Discovery of New Therapeutic Targets in ALL
$623,226Gary L. Gilliland · Dana-Farber Cancer Inst · P01 · FY2009 · CA
Information flow and state transitions at the system and multi-dimensional scales in leukemia progression
$623,198Russell Christian Rockne · Beckman Research Institute/City Of Hope · U01 · FY2024 · CA
Nuclear Medicine Core
$623,183Joseph G Rajendran · Fred Hutchinson Cancer Research Center · P01 · FY2015 · CA
RETROVIRUS EVOLUTION
$623,155Tufts University Boston · R01 · FY2004 · CA
Molecular and cellular mechanisms of neuronal damage caused by anticancer therapies
$623,067Joseph G Duman · Baylor College Of Medicine · R01 · FY2025 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP--WISCONSIN STUDIES
$623,064University Of Wisconsin Madison · U10 · FY2003 · CA
NCTN Lead Academic Participating Sites Application
$623,050Lisa A Carey · Univ Of North Carolina Chapel Hill · U10 · FY2014 · CA
Genetic Epidemiology of Chronic Lymphocytic Leukemia
$622,973Susan L Slager · Mayo Clinic Rochester · U01 · FY2008 · CA
The role of inflammation in driving leukemogenesis in germline predisposition syndromes
$622,915Lucy Ann Godley · Northwestern University At Chicago · U01 · FY2024 · CA